Elucidation of the structural basis of interaction of the BCR-ABL kinase inhibitor, nilotinib (Tasigna(®)) with the human ABC drug transporter P-glycoprotein

Detalles Bibliográficos
Autores principales: Shukla, Suneet, Chufan, Eduardo E., Singh, Satyakam, Skoumbourdis, Amanda P., Kapoor, Khyati, Boxer, Matthew B., Duveau, Damien Y., Thomas, Craig J., Talele, Tanaji T., Ambudkar, Suresh V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981924/
https://www.ncbi.nlm.nih.gov/pubmed/24418991
http://dx.doi.org/10.1038/leu.2014.21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981924/
https://www.ncbi.nlm.nih.gov/pubmed/24418991
http://dx.doi.org/10.1038/leu.2014.21

Ejemplares similares